These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro and in vivo effects of polyhaemoglobin-tyrosinase on murine B16F10 melanoma. Yu B; Swi Chang TM Melanoma Res; 2004 Jun; 14(3):197-202. PubMed ID: 15179188 [TBL] [Abstract][Full Text] [Related]
4. Effects of combined oral administration and intravenous injection on maintaining decreased systemic tyrosine levels in rats. Yu B; Chang TM Artif Cells Blood Substit Immobil Biotechnol; 2004 Feb; 32(1):129-48. PubMed ID: 15027806 [TBL] [Abstract][Full Text] [Related]
5. Preparation of well-defined bovine polyhemoglobin based on dimethyl adipimidate and glutaraldebyde cross-linkage. Hu T; Su Z Biochem Biophys Res Commun; 2002 May; 293(3):958-61. PubMed ID: 12051752 [TBL] [Abstract][Full Text] [Related]
7. A natural compound (reuterin) produced by Lactobacillus reuteri for hemoglobin polymerization as a blood substitute. Chen YC; Chang WH; Chang Y; Huang CM; Sung HW Biotechnol Bioeng; 2004 Jul; 87(1):34-42. PubMed ID: 15211486 [TBL] [Abstract][Full Text] [Related]
8. Polyhemoglobin-fibrinogen: a novel oxygen carrier with platelet-like properties in a hemodiluted setting. Wong NS; Chang TM Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(5):481-9. PubMed ID: 17922313 [TBL] [Abstract][Full Text] [Related]
9. Effects of long-term oral administration of polymeric microcapsules containing tyrosinase on maintaining decreased systemic tyrosine levels in rats. Yu B; Chang TM J Pharm Sci; 2004 Apr; 93(4):831-7. PubMed ID: 14999721 [TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of a silk protein-based matrix for the enzymatic conversion of tyrosine to L-DOPA. Acharya C; Kumar V; Sen R; Kundu SC Biotechnol J; 2008 Feb; 3(2):226-33. PubMed ID: 18034433 [TBL] [Abstract][Full Text] [Related]
11. PEG-PLA Nanocapsules Containing a Nanobiotechnological Complex of Polyhemoglobin-Tyrosinase for the Depletion of Tyrosine in Melanoma: Preparation and Fustier C; Chang TM J Nanomedine Biotherapeutic Discov; 2012 Mar; 2(1):1-9. PubMed ID: 23569713 [TBL] [Abstract][Full Text] [Related]
12. Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma. Di Nicola M; Carlo-Stella C; Mortarini R; Baldassari P; Guidetti A; Gallino GF; Del Vecchio M; Ravagnani F; Magni M; Chaplin P; Cascinelli N; Parmiani G; Gianni AM; Anichini A Clin Cancer Res; 2004 Aug; 10(16):5381-90. PubMed ID: 15328176 [TBL] [Abstract][Full Text] [Related]
13. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers. Lillehammer T; Tveito S; Engesaeter BO; Fodstad O; Maelandsmo GM; Engebraaten O Cancer Gene Ther; 2005 Nov; 12(11):864-72. PubMed ID: 15891771 [TBL] [Abstract][Full Text] [Related]
14. Polyhemoglobin with different percentage of tetrameric hemoglobin and effects on vasoactivity and electrocardiogram. Yu B; Liu Z; Chang TM Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(2):159-73. PubMed ID: 16537172 [TBL] [Abstract][Full Text] [Related]
15. Direct immobilization of tyrosinase enzyme from natural mushrooms (Agaricus bisporus) on D-sorbitol cinnamic ester. Marín-Zamora ME; Rojas-Melgarejo F; García-Cánovas F; García-Ruiz PA J Biotechnol; 2006 Nov; 126(3):295-303. PubMed ID: 16730834 [TBL] [Abstract][Full Text] [Related]
16. Nanobiotechnological modification of hemoglobin and enzymes from this laboratory. Chang TM Biochim Biophys Acta; 2008 Oct; 1784(10):1435-40. PubMed ID: 18565337 [TBL] [Abstract][Full Text] [Related]
17. [Effect of polyhemoglobin composition on erythrocyte aggregation and circulation time in the vascular bed]. Litvinenko IuA; Azhigirova MA; Viazova EP; Shuvalova AL; Sokolov AV; Kolonina IR Biull Eksp Biol Med; 1993 Jan; 115(1):27-9. PubMed ID: 8054567 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma. Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991 [TBL] [Abstract][Full Text] [Related]
19. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene. Morita N; Hiratsuka J; Kondoh H; Uno M; Asano T; Niki Y; Sakurai Y; Ono K; Harada T; Imajo Y Cancer Res; 2006 Apr; 66(7):3747-53. PubMed ID: 16585201 [TBL] [Abstract][Full Text] [Related]